Ab&B Bio Tech Co Ltd.
HKSE: 2627.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Youcai An
- Employees
- 583
- Headquarters
- Taizhou, China
- IPO year
- 2025
- Market cap
- HK$10.6B
- Website
- https://www.abbbio.com
Loading 2627…
Loading profile data…Frequently asked questions about 2627
What does Ab&B Bio Tech Co Ltd. (2627.HK) do?
Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases. The company offers various vaccines, such as human rabies vaccine, pneumococcal vaccine, zoster vaccine, respiratory syncytial virus vaccine, mpox vaccine, varicella vaccine, and tetanus vacc...
Where does 2627.HK trade?
Ab&B Bio Tech Co Ltd. (2627.HK) trades on the Hong Kong Stock Exchange.
What sector is 2627.HK in?
Ab&B Bio Tech Co Ltd. (2627.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Ab&B Bio Tech Co Ltd.?
Youcai An is the chief executive officer of Ab&B Bio Tech Co Ltd. (2627.HK).
Where is Ab&B Bio Tech Co Ltd. headquartered?
Ab&B Bio Tech Co Ltd. is headquartered in China.
Does 2627.HK pay a dividend?
Ab&B Bio Tech Co Ltd. (2627.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 2627.HK go public?
Ab&B Bio Tech Co Ltd. (2627.HK) completed its initial public offering in 2025.